A strategic partnership between Shear Kershman Laboratories, Texas A&M University College of Dentistry, and Innovative MedTech Inc. aims to transform oral healthcare through innovative medical solutions. The collaboration focuses on developing BioViscid™, a pioneering bio-adhesive formulation designed to treat oral thrush with unprecedented effectiveness. This technology represents a significant advancement in addressing a condition that affects approximately 5-7% of Americans, particularly those with compromised immune systems.
BioViscid™ distinguishes itself from existing treatments by providing a sustained-release mechanism that adheres directly to mucosal tissues. Early trials demonstrate the formulation maintains its therapeutic properties for 6-8 hours post-application, even in high-moisture environments. Unlike traditional systemic treatments such as fluconazole, BioViscid™ offers targeted application that bypasses first-pass metabolism, potentially improving treatment outcomes for patients.
The global market for oral candidiasis treatments is estimated between $4-6 billion, with potential for significant growth. By developing this innovative drug delivery system, the partnership aims to address critical challenges in oral health and patient care. Key objectives include jointly developing advanced technologies, enhancing academic training programs, and conducting groundbreaking research to improve patient outcomes globally.
Dr. Lily T. Garcia, Dean of Texas A&M College of Dentistry, emphasized the transformative potential of this interdisciplinary approach, noting that the partnership exemplifies how science, technology, and patient care can converge to create meaningful innovations. The anticipated impact extends beyond oral thrush treatment, with potential developments including novel drug delivery methods for oral diseases and innovative solutions for underserved healthcare communities. This collaboration represents a significant step forward in addressing a widespread health concern through targeted, effective treatment options.
